Skip to content

Clinical trials

Phase 1/2 Adenocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 1/2 Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20061
20081
20092
20103
20111
20121
20131
20141
20173
20181
20192
20204
20213
20223
20232
20241
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting7
Active, not recruiting5
Terminated4
Withdrawn2
Suspended2
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Abramson Cancer Center at Penn Medicine2
Immuneering Corporation2
Ohio State University Comprehensive Cancer Center2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
ARCA Biopharma, Inc.1
Acrotech Biopharma Inc.1
Alan Katz1
Antelope Surgical Solutions, Inc1
Aravive, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma42
Carcinoma, Non-Small-Cell Lung12
Neoplasms11
Pancreatic Neoplasms11
Neoplasm Metastasis8
Lung Neoplasms7
Colonic Neoplasms6
Ovarian Neoplasms5
Colorectal Neoplasms4
Prostatic Neoplasms4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.